Products for Research Use Only
RegisterLogin

Simaravibart

CAT: 0804-HY-P990052-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P990052-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Simaravibart (MAD-0004J08) is an IgG1κ antibody targeting the SARS-CoV2 spike (S) glycoprotein receptor binding domain[1].
CAS Number
2657609-23-7
Product Name Alternative
MAD-0004J08
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/simaravibart.html
Purity
98.59
Solubility
10 mM in DMSO
Smiles
[Simaravibart]
Molecular Weight
(144.955 kDa)
References & Citations
[1]Lim SP. Targeting SARS-CoV-2 and host cell receptor interactions. Antiviral Res. 2023 Feb;210:105514.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T80575-01Simaravibart
GTR18398537-01Simaravibart Antibody
WA3535Research Grade Simaravibart
E55B1026Simaravibart (Reference antibody)
ICH5865-10mgSimaravibart Biosimilar - Research Grade
A136213Simaravibart Biosimilar (Monoclonal, IgG1-kappa)
GTR18696583-01Simaravibart Human Monoclonal Antibody
GTR18780396-01(Simaravibart) Biosimilar Reference Antibody
RA0664-01Simaravibart (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD)
PX-TA1935-01Simaravibart Biosimilar - Anti-SARS-CoV-2 RBD mAb - Research Grade

Popular Products